Lipofabrik Overview

  • Founded
  • 2012

Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 12

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Lipofabrik General Information

Description

Developer of biological and biodegradable molecules designed to offer products through bio-processes based renewable resources. The company's molecules are prepared by doing research on dipeptides that are produced by a bacterial class, enabling healthcare companies to get advanced products for feeding animals and for treating diseases.

Contact Information

Website
www.lipofabrik.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Agriculture
Drug Discovery
Parent Company
Elephant Vert
Primary Office
  • 917 rue des Saules
  • 59810 Lesquin
  • France
+33 03 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lipofabrik Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 31-Jan-2022 00.000 Completed Generating Revenue
6. Grant 01-Apr-2019 00.000 00.000 Completed Generating Revenue
5. Later Stage VC (Series A) 01-Mar-2018 00.000 00.000 00.00 Completed Startup
4. Grant 15-Dec-2017 000.00 00.00 Completed Startup
3. Early Stage VC 03-Jun-2015 00000 00.00 00.000 Completed Startup
2. Angel (individual) 19-Dec-2013 $641K $641K 00.00 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Lipofabrik’s complete valuation and funding history, request access »

Lipofabrik Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preference 0,000 0000.000000 00000.0 00000.0 00 00000.0 00.000
Preference 000 0000.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary 376 $12.345135 $1543.14 $1543.14 1x $1543.14 8.48%
To view Lipofabrik’s complete cap table history, request access »

Lipofabrik Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biological and biodegradable molecules designed to offer products through bio-processes based renewable res
Biotechnology
Lesquin, France
12 As of 2022
00.000
000000&0 00.000

000000

fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in
0000 000000000
New York, NY
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

000000

inim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea com
0000 000000000
Barcelona, Spain
00 As of 0000
000.00
00000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lipofabrik Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Volastra Venture Capital-Backed New York, NY 00 00000 00000000000 00000
0000000 000000 Venture Capital-Backed Barcelona, Spain 00 000.00 00000 00000
000 000000000000 Venture Capital-Backed Barcelona, Spain 00 0000 00000000000 0000
00 000000000000 Formerly VC-backed Durham, NC 000 00000 00000000 00000
To view Lipofabrik’s complete competitors history, request access »

Lipofabrik Patents

  • 18

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Lipofabrik Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018303287-A1 Composition comprising a high concentration of iturin lipopeptides Pending 21-Jul-2017 000000000
CA-3069760-A1 Composition comprising a high concentration of iturin lipopeptides Pending 21-Jul-2017 000000000
EP-3654945-A1 Composition comprising a high concentration of iturin lipopeptides Pending 21-Jul-2017 000000000
FR-3069155-A1 Composition comprising a high concentration of iturinic lipopeptides Active 21-Jul-2017 000000000 0
FR-3069155-B1 Composition comprising a high concentration in iturinic lipopeptides Active 21-Jul-2017 A61K9/107
To view Lipofabrik’s complete patent history, request access »

Lipofabrik Executive Team (3)

Name Title Board Seat Contact Info
Arnaud Delecroix Chief Executive Officer
François Coutte Co-Founder, Partner & Scientific Advisor
Philippe Jacques Co-Founder, Partner & Scientific Advisor
To view Lipofabrik’s complete executive team members history, request access »

Lipofabrik Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lipofabrik Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Eurasanté Bio Incubator Accelerator/Incubator 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
Nord France Amorçage Venture Capital Minority 000 0000 000000 0
Roquette Ventures Corporate Venture Capital Minority 000 0000 000000 0
Siparex Group PE/Buyout Minority 000 0000 000000 0
To view Lipofabrik’s complete investors history, request access »

Ready to get started?

Request a free trial